Onegen Bio Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -183.56%
- Ebitda -129.49%
- Net Worth -1017.88%
- Total Assets -0.60%
About Onegen Bio
Onegen Bio Private Limited (OBPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 December 2018 (Six years and one month 17 days old ). Its registered office is in Krishna, Andhra Pradesh, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Meda Anand and Lakshmi Nimmagadda serve as directors at the Company.
Company Details
-
Location
Krishna, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U01110AP2018PTC110090
-
Company No.
110090
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Dec 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Onegen Bio?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meda Anand
|
Director | 25-Sep-2023 | Current |
|
Lakshmi Nimmagadda
|
Director | 28-Dec-2018 | Current |
Financial Performance of Onegen Bio.
Onegen Bio Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 183.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1017.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Onegen Bio?
Unlock access to Onegen Bio's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tekoalyn Labs Innovative Software Solutions Private LimitedMeda Anand is a mutual person
-
Dare Engineering Private LimitedMeda Anand and Lakshmi Nimmagadda are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Onegen Bio?
Unlock and access historical data on people associated with Onegen Bio, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Onegen Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onegen Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
